GW Henssler & Associates’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,786
Closed -$280K – 226
2023
Q2
$280K Sell
2,786
-700
-20% -$64.9K 0.02% 152
2023
Q1
$283K Buy
3,486
+42
+1% +$3.37K 0.02% 177
2022
Q4
$257K Hold
3,444
– – 0.02% 189
2022
Q3
$285K Buy
3,444
+464
+16% +$40.7K 0.02% 151
2022
Q2
$238K Buy
+2,980
New +$302K 0.02% 182

Other funds holding DVA

GW Henssler & Associates's DVA Position: Q3 2023 in Review

GW Henssler & Associates sold out of DaVita (DVA) in Q3 2023, closing a stake of 2,786 shares — an estimated $280K sold.

GW Henssler & Associates first reported a position in DVA in Q2 2022 and held it in 5 quarters. The position peaked at $285K in Q3 2022. 503 funds tracked by Wall St. Rank hold DVA as of Q3 2023.

  • GW Henssler & Associates reported no remaining DaVita position as of Q3 2023 after selling out during the quarter.
  • GW Henssler & Associates sold 2,786 DaVita shares in Q3 2023, an estimated $280K.
  • GW Henssler & Associates first reported a position in DaVita in Q2 2022 and held it in 5 quarters.
  • GW Henssler & Associates's DaVita position peaked at $285K in Q3 2022.
  • 503 funds tracked by Wall St. Rank held DaVita as of Q3 2023.

Based on GW Henssler & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.